Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression—risks, screening, diagnosis and management

BACKGROUND: One quarter of the world's population has latent tuberculosis infection (LTBI). Systemic immunosuppression is a risk factor for LTBI reactivation and the development of active tuberculosis. Such reactivation carries a risk of significant morbidity and mortality. Despite the increasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fehily, Sasha R., Al‐Ani, Aysha H., Abdelmalak, Jonathan, Rentch, Clarissa, Zhang, Eva, Denholm, Justin T., Johnson, Douglas, Ng, Siew C., Sharma, Vishal, Rubin, David T., Gibson, Peter R., Christensen, Britt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325436/
https://www.ncbi.nlm.nih.gov/pubmed/35596242
http://dx.doi.org/10.1111/apt.16952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325436/
https://www.ncbi.nlm.nih.gov/pubmed/35596242
http://dx.doi.org/10.1111/apt.16952

Ejemplares similares